These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32456472)

  • 1. Influence of cerebrospinal fluid drainage and other variables on the plasma vancomycin trough levels in postoperative neurosurgical patients.
    Chen C; Xu P; Xu T; Zhou K; Zhu S
    Br J Neurosurg; 2021 Apr; 35(2):133-138. PubMed ID: 32456472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of cerebral fluid drainage on the pharmacokinetics of vancomycin in neurosurgical patients.
    Ichie T; Urano K; Suzuki D; Okada T; Kobayashi N; Hayashi H; Sugiura Y; Yamamura K; Sugiyama T
    Pharmazie; 2015 Jun; 70(6):404-9. PubMed ID: 26189303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the Factors Affecting the Transferability of Vancomycin to Cerebrospinal Fluid in Postoperative Neurosurgical Patients with Bacterial Meningitis.
    Ichinose N; Shinoda K; Yoshikawa G; Fukao E; Enoki Y; Taguchi K; Oda T; Tsutsumi K; Matsumoto K
    Biol Pharm Bull; 2022; 45(9):1398-1402. PubMed ID: 36047211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between vancomycin penetration into cerebrospinal fluid and protein concentration in cerebrospinal fluid/serum albumin ratio.
    Ishikawa M; Yamazaki S; Suzuki T; Uchida M; Iwadate Y; Ishii I
    J Infect Chemother; 2019 Feb; 25(2):124-128. PubMed ID: 30424949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive performance of reported vancomycin population pharmacokinetic model in patients with different renal function status, especially those with augmented renal clearance.
    Yu YX; Lu J; Lu HD; Li L; Li JJ; Shi L; Duan LF; Zhuang ZW; Xue SD; Shen Y; Tang L
    Eur J Hosp Pharm; 2022 Mar; 29(e1):e6-e14. PubMed ID: 33414258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of influencing factors of trough serum vancomycin concentrations in critically ill neurosurgical patients].
    Yao M; Li J; Shi L; Wang Y; Wang L; Guan X; Ouyang B
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Nov; 31(11):1384-1388. PubMed ID: 31898570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmented Renal Clearance in Patients With Febrile Neutropenia is Associated With Increased Risk for Subtherapeutic Concentrations of Vancomycin.
    Hirai K; Ishii H; Shimoshikiryo T; Shimomura T; Tsuji D; Inoue K; Kadoiri T; Itoh K
    Ther Drug Monit; 2016 Dec; 38(6):706-710. PubMed ID: 27681114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for vancomycin nephrotoxicity and time course of renal function during vancomycin treatment.
    Hirai T; Hanada K; Kanno A; Akashi M; Itoh T
    Eur J Clin Pharmacol; 2019 Jun; 75(6):859-866. PubMed ID: 30770940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An investigation into the vancomycin concentration in the cerebrospinal fluid due to vancomycin intraventricular administration in newborns: a study of 13 cases.
    Matsunaga N; Hisata K; Shimizu T
    Medicine (Baltimore); 2015 Jun; 94(22):e922. PubMed ID: 26039127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of a Nomogram for Achieving Target Trough Concentration of Vancomycin: Accuracy in Patients With Augmented Renal Function.
    Ishii H; Hirai K; Sugiyama K; Nakatani E; Kimura M; Itoh K
    Ther Drug Monit; 2018 Dec; 40(6):693-698. PubMed ID: 30157096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship Between Initial Vancomycin Trough Levels and Early-Onset Vancomycin-Associated Nephrotoxicity in Critically Ill Patients.
    Chuma M; Makishima M; Imai T; Tochikura N; Suzuki S; Kuwana T; Sawada N; Komatsu T; Sakaue T; Kikuchi N; Yoshida Y; Kinoshita K
    Ther Drug Monit; 2018 Feb; 40(1):109-114. PubMed ID: 29095798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duration of Systemic Inflammatory Response Syndrome Influences Serum Vancomycin Concentration in Patients With Sepsis.
    Chuma M; Makishima M; Imai T; Tochikura N; Sakaue T; Kikuchi N; Kinoshita K; Kaburaki M; Yoshida Y
    Clin Ther; 2016 Dec; 38(12):2598-2609. PubMed ID: 27836495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of serum concentration and concomitant drugs on vancomycin-induced acute kidney injury in haematologic patients: a single-centre retrospective study.
    Okada N; Chuma M; Azuma M; Nakamura S; Miki H; Hamano H; Goda M; Takechi K; Zamami Y; Abe M; Ishizawa K
    Eur J Clin Pharmacol; 2019 Dec; 75(12):1695-1704. PubMed ID: 31511938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low vancomycin trough concentration in neonates and young infants.
    Maruyama H; Tanzawa A; Funaki T; Ito Y; Isayama T
    Pediatr Int; 2021 May; 63(5):556-560. PubMed ID: 32894884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Validating the Effectiveness of Switching the Vancomycin TDM Analysis Software Based on the Predictive Accuracy].
    Imai S; Yamada T; Ishiguro N; Miyamoto T; Kagami K; Tomiyama N; Niinuma Y; Nagasaki D; Suzuki K; Yamagami A; Kasashi K; Kobayashi M; Iseki K
    Yakugaku Zasshi; 2017; 137(9):1185-1192. PubMed ID: 28867705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic monitoring of cerebrospinal fluid vancomycin concentrations and analysis of their influencing factors in neurosurgical intensive care unit patients].
    Yao M; Li J; Shi L; Li Y; Wang L; Guan X; Ouyang B
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Oct; 31(10):1252-1257. PubMed ID: 31771724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lower vancomycin trough levels in adults undergoing unrelated cord blood transplantation.
    Yasu T; Konuma T; Oiwa-Monna M; Kato S; Isobe M; Takahashi S; Tojo A
    Leuk Lymphoma; 2021 Feb; 62(2):348-357. PubMed ID: 33100069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Regression Model to Predict Augmented Renal Clearance in Critically Ill Obstetric Patients and Effects on Vancomycin Treatment.
    Tang L; Ding XY; Duan LF; Li L; Lu HD; Zhou F; Shi L; Lu J; Shen Y; Zhuang ZW; Sun JT; Zhou Q; Zhu CQ; Li JJ; Yu YX
    Front Pharmacol; 2021; 12():622948. PubMed ID: 34177564
    [No Abstract]   [Full Text] [Related]  

  • 19. Involvement of the effect of renal hypoperfusion medications on vancomycin trough concentration: A secondary analysis using a retrospective observational data.
    Hirai T; Hanada K; Iwamoto T; Itoh T
    Basic Clin Pharmacol Toxicol; 2021 Nov; 129(5):376-384. PubMed ID: 34396691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of high Vancomycin trough concentration with acute kidney injury during combination therapy of Piperacillin/Tazobactam and Vancomycin.
    Saito S; Sugimoto T; Takenaka K; Goto H; Kumahara A; Watanabe R; Sugiyama D; Yasutomo Y; Takatsuki K
    Pract Lab Med; 2022 Mar; 29():e00266. PubMed ID: 35111893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.